Latest results FY2025 · Prices updated Oct 30, 2026
HQ: Nakano, TokyoFounded 19071,067 employeesWebsite
A leading Japanese beverage group. It operates globally in beverages, pharmaceuticals, and health sciences, driven by its core strengths in fermentation and biotechnology.
Business segments (share of revenue)
Latest results
FY2025
vs. same period a year earlier
Company forecastFY2026
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Alcoholic Beverages Business | 45% | ¥1.1T | ¥135.4B | 12.6% |
| Non-Alcoholic Beverages Business | 24% | ¥578.2B | ¥67.7B | 11.7% |
| Pharmaceuticals Business | 21% | ¥496.5B | ¥102.3B | 20.6% |
| Health Science Business | 10% | ¥251.4B | ¥11.1B | 4.4% |
Close (Oct 30, 2026)
¥2,891.5+33.7% (1Y)
Kirin +33.7% over 1Y, 17.1pt above the industry average (38 companies, +16.6%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2025FY | ¥2.4T | — | ¥147.5B | ¥3.5T | +4.1% |
| 2024FY | ¥2.3T | ¥125.3B | ¥58.2B | ¥3.4T | +9.6% |
| 2023FY | ¥2.1T | ¥150.3B | ¥112.7B | — | +7.3% |
| 2022FY | ¥2.0T | ¥116.0B | ¥111.0B | — | +9.2% |
| 2021FY | ¥1.8T | ¥68.1B | ¥59.8B | — | — |
Sources: annual securities reports, earnings releases and other public disclosures (Dec 2024)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
